国际权威认证!中科英海成功获批OECD GLP资质 全球化服务再升级
Internationally Authoritative Certification Achieved! Zhongke EnHealth Successfully Obtains OECD GLP Accreditation, Upgrading Its Global Services

发布时间:2026-01-28


广东中科英海科技有限公司(以下简称中科英海)近日正式获得由墨西哥EMA颁发的OECD GLP(良好实验室规范)资质认证证书。这是中科英海首次取得该项国际公认的质量管理体系认证,标志着公司在检测服务能力、数据可靠性与质量管理方面全面对接国际标准,为服务全球市场注入强劲动能。

Guangdong Zhongke EnHealth Science and TechnologyCo., Ltd. (hereinafter referred to as "ZhongkeEnHealth") has recently been officially awardedthe OECD GLP (Good Laboratory Practice) certification certificate issued byMexico's EMA. This marks Zhongke EnHealth's first acquisition of thisinternationally recognized quality management system certification, signifyingthat the company has fully aligned its testing service capabilities, datareliability and quality management with international standards, and injectedstrong impetus into serving the global market.



一次性顺利通过评审,彰显专业实力

Passed theassessment successfully, demonstratingexceptional professional strength


202591日至2日,OECD GLP评审专家组对中科英海进行了全面严格的现场审核。评审覆盖实验室设施、人员能力、实验流程、数据完整性与质量管理体系等各个环节。公司凭借规范的操作流程、严谨的数据管理和高效的质量体系,赢得专家组一致认可,并于20251217日正式获颁证书。值得关注的是,中科英海在残留试验能力建设与OECD GLP质量体系建设过程中得到了项目合作公司拜耳作物科学(中国)有限公司膳食安全专家孙建鹏的专业指导,对标高标准,成为国内首家取得残留试验(室内分析与田间试验)OECD GLP资质的单位,填补了国内该领域国际资质认证的空白。

From September 1st to 2nd, 2025, the OECD GLP assessment expertpanel conducted a comprehensive and rigorous on-site audit of Zhongke EnHealth.The assessment covered all aspects including laboratory facilities, personnelcapabilities, experimental procedures, data integrity and quality managementsystems. Relying on standardized operational procedures, rigorous datamanagement and an efficient quality system, the company won the unanimousrecognition of the expert panel and was officially awarded the certificate onDecember 17th, 2025. Notably, during the development of its residue testingcapabilities and OECD GLP quality system, Zhongke EnHealth received professionalguidance from Jianpeng Sun, a dietary safety expert at Bayer CropScience(China) Co.,Ltd., a project cooperation company.By benchmarking against high international standards, Zhongke EnHealth hasbecome the first domestic entity to obtain OECD GLP certification for residuetesting (laboratory analysis and field trials), filling the gap ininternational certification for this field in China.


多领域资质落地,覆盖核心检测需求

Qualifications Secured Across MultipleFields, Covering Core Testing Requirements


本次认证涵盖以下关键检测领域,可为企业提供符合国际标准的检测服务:

This certification covers the following key testing areas, enablingthe company to provide testing services that comply with internationalstandards for enterprises.


农药与化学品领域:

Pesticides and Industrial Chemicals

  • 毒性试验:急性经口毒性试验、急性经皮毒性试验、急性眼刺激性/腐蚀性试验、多次皮肤刺激性/腐蚀性试验、急性皮肤刺激性/腐蚀性试验、皮肤变态反应(致敏)试验、急性吸入毒性试验、亚急性毒性试验、亚慢性毒性试验、生殖/发育毒性筛选试验、孕期发育毒性试验、两代繁殖毒性试验等。
  • Toxicity studies: Acute oral toxicity test, Acute dermal toxicity test, Acute eye irritation/corrosion test, Repeated dermal irritation/corrosion test, Acute dermal irritation/corrosion test, Skin sensitization test, Acute inhalation toxicity test, Subacute toxicity test, Subchronic toxicity test, Reproductive/developmental toxicity screening test, Developmental toxicity test during pregnancy, Two-generation reproductive toxicity test etc.

  • 致突变试验:鼠伤寒沙门氏菌细菌回复突变试验(Ames)、体外哺乳动物细胞Hprt基因突变试验、体内哺乳动物骨髓红细胞微核试验、体外哺乳动物细胞微核试验、体外哺乳动物细胞染色体畸变试验、哺乳动物体内碱性彗星试验等。
  • Mutagenicity studies: Bacterial reverse mutation test, In vitro mammalian cell Hprt gene mutation test, In vivo mammalian bone marrow erythrocyte micronucleus test, In vitro mammalian cell micronucleus test, In vitro mammalian cell chromosome aberration test, In vivo mammalian alkaline comet assay etc.

  • 残留试验:室内分析、田间试验。
  • Residue studies: Field studies (plants) Agricultural chemicals,etc.

  • 分析化学和临床化学测试:农业样本与生物样本中残留物分析、毒性病理测试。
  • Analytical and clinicalchemistry testing: Analysis of residues in agricultural samples and biological samples,Veterinary clinical pathology etc.

  • 获得OECD GLP资质,意味着中科英海出具的相关检测数据将在所有OECD成员国及数据互认协议(MAD)履约国获得认可,显著助力客户加速产品国际注册,降低合规成本。
  • Obtaining the OECD GLP certification meansthat the relevant testing data issued by Zhongke EnHealth will be recognized inall OECD member countries and signatory countries to the Mutual Acceptance ofData (MAD) Agreement, which significantly helps customers accelerate theinternational registration of their products and reduce compliance costs.


赋能全球合规布局,诚邀客户携手共赢

Empowering Global Compliance Layouts,Sincerely Inviting Customers to Join Hands for Win-Win Cooperation


中科英海始终秉持诚信、公正、业精、卓越的质量方针。此次认证不仅是公司技术与管理实力的体现,更是全球化战略的重要里程碑。未来,中科英海将持续提升检测服务水平,为国内外客户提供高效、可靠的一站式合规解决方案。

即日起,中科英海正式面向全球开放OECD GLP范畴内的检测服务。欢迎国内外客户垂询合作,携手开拓国际市场,共创共赢新局面!

Zhongke EnHealth has always adhered to the quality policy of"Integrity, Impartiality, Professional Excellence and Pursuit ofPerfection". This certification is not only a reflection of the company'stechnical and management strength, but also an important milestone in itsglobalization strategy. Going forward, Zhongke EnHealth will continue toelevate the standard of its testing services and provide efficient, reliableone-stop compliance solutions for customers at home and abroad.

Effective immediately, Zhongke EnHealth officially launches itstesting services under the OECD GLP framework to the global market. We welcomeinquiries and cooperation from customers worldwide, and look forward to joininghands to explore the international market and create a new chapter of win-windevelopment!






联系方式Contact Information

广东中科英海科技有限公司Guangdong Zhongke EnHealthScience and Technology Co., Ltd.

电话Tel+86-757-28835265+86-13322818035

邮箱Emailcs201@zkenhealth.com

官网Websitehttp://www.zkenhealth.com/



0757-28835916
0757-82583580
邮箱:enhealth@126.com
总部:广东省佛山市顺德区乐从镇佛山新城汾江南路235号依云国际2座2楼
分部:广东省佛山市南海区桂城街道宝石西路天富科技城4号楼4楼